STEPHENS KRISTIN (Chief Development Officer) sold 36.13K shares of SYROS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $7.9K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/20/2024ACC: 0000950170-24-129384
Officer· Chief Development Officer
Since Jun 2021
-36.13K
Net shares
Net seller
$7.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
36.13K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−36.13K
Price / share
$0.22
Trade value
$7.95K
% of position
New position
11/18/2024
36.13K→0.00
Total
Net shares
−36.13K
Net value
-$7.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2024 | S · Sale | −36.13K | $0.22 | $7.95K | New position | 36.13K | 0.00 |
| Total | −36.13K | -$7.95K | ||||||
Derivative Transactions0
No derivative transactions reported